Multiplexed Mass Spectrometry Assay Identifies Neurodegeneration Biomarkers in CSF

Home > Science Hub > Multiplexed Mass Spectrometry Assay Identifies Neurodegeneration Biomarkers in CSF
Back to the list

June 9, 2017

Pascal Croteau¹, Fiona McAllister¹, Laura McIntosh¹, Laetitia Cortes¹, Michael Schirm¹, Howard Schulman¹, Jane Paulsen², Daniel Chelsky¹. ¹Caprion Biosciences Inc, Montreal, Canada; ²The University of Iowa, Iowa City, IA.

Multiplexed Mass Spectrometry Assay Identifies Neurodegeneration Biomarkers in CSF, CNS Summit 2017

Multiplexed Mass Spectrometry Assay Identifies Neurodegeneration Biomarkers in CSF

Download poster

You might also be interested by

Posters

Can Microsampling Devices Coupled with Intact Mass High-Resolution Mass Spectrometry Improve M-Protein Monitoring and Simplify Minimal Residual Disease Assessment in Multiple Myeloma?

November 10, 2025

Proteomics/Mass Spectrometry

More info

Web News

CellCarta Expands Proteomics Offering with Olink® Reveal Assay

August 6, 2025

Proteomics/Mass Spectrometry

More info

Brochures & Infographics

Supporting Your Targeted Protein Degradation Strategies

April 1, 2025

Proteomics/Mass Spectrometry

More info

Web News

CellCarta Joins Olink™ Certified Service Provider Network in China

February 13, 2025

Proteomics/Mass Spectrometry

More info